RxDoctor Payments Data

Ryan Lundell, MD

Anatomic Pathology & Clinical Pathology · Rochester, MNNPI 1841261286

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Stemline Therapeutics Inc. at 26.8% of the total. Reporting peaked in 2019 at $185 and has fallen 76.6% since, to $43 in 2023.

$388in general payments, 2019–2025

Across 8 payments — averaging $48.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$104
  • Pfizer$81
  • Bristol Myers Squibb$58
  • Lilly USA, LLC$56
  • Novartis$46
  • Johnson & Johnson$43

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 70th percentile of 92 anatomic pathology & clinical pathology providers in Minnesota.

See all anatomic pathology & clinical pathology providers in Minnesota

Medicare billing

Part B allowed, 2024
$252,495
Medicare patients
1,975
Services billed
5,406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →